Managing potassium to optimize therapy in heart failure - PACE-CME

Managing potassium to optimize therapy in heart failure

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Optimizing GDMT in HF with digital consults
Optimizing GDMT in HF with digital consults
ESC Congress 2024
Optimizing GDMT in HF with digital consults
- Mark Schuuring, MD, PhD
Effects of empaglifozin on kidney outcomes after acute MI
Effects of empaglifozin on kidney outcomes after acute MI
ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
- Deepak Bhatt, MD
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
ESC Congress 2024
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
- Scott Solomon, MD
Disease-modifying effects of finerenone in CKM syndrome
Disease-modifying effects of finerenone in CKM syndrome
ESC Congress 2024
Disease-modifying effects of finerenone in CKM syndrome
- Muthiah Vaduganathan, MD